Baird Maintains a 'Outperform' on Celgene (CELG); Nothin' But Upside
Tweet Send to a Friend
Baird maintains a 'Outperform' on Celgene (NASDAQ: CELG) price target of $78.00.
Analyst, Christopher Raymond, said, "Incrementally positive on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Christopher Raymond, said, "Incrementally positive on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


